2007 – 2009 Publications

/2007 – 2009 Publications
2007 – 2009 Publications 2013-11-26T12:57:05+00:00
1Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for greater than 12 months in Lusaka, ZambiaChi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC, Reid SE, Bulterys M, Mwinga A, Saag MS, Stringer JSA2009
2Causes of morbidity among children on antiretroviral therapy in Lusaka, ZambiaMubiana-Mbewe M, Bolton-Moore C, Banda Y, Chintu N, Nalubamba-Phiri M, Guffey MB, Sambo P, Stringer EM, Stringer JSA, Chi BH2009
3CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, ZambiaChi BH, Giganti M, Mulenga PL, Limbada M, Reid SE, Mutale W, Stringer JSA2009
4HIV disease progression by hormonal contraception method: secondary analysis of a randomized trialStringer EM, Levy J, Sinkala M, Chi BH, Chintu N, Kaseba C, Stringer JSA2009
5HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trialKapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH2009
6Hormonal contraception and HIV disease progression: a multi-country cohort analysis of the MTCT-Plus InitiativeStringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JSA2009
7Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomesKilewo C, Natchu UCM, Young A, Donnell D, Brown E, Read JSA, Sharma U, Chi BH, Goldenberg R, Hoffman I, Taha TE, Fawzi WW2009
8Implementation of a “see-and-treat” cervical cancer prevention services linked to HIV care in ZambiaMwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Parham GP2009
9Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV preventionChi BH, Ellis GM, Chintu N, Cantrell RA, Sinkala M, Aldrovandi GM, Warrier R, Mbewe F, Nakamura K, Stringer EM, Frenkel LM, Stringer JSA2009
10Lost but not forgotten – the economics of improving patient retention in AIDS treatment programsBisson GP, Stringer JSA2009
11Macronutrient supplementation to improve outcomes among adults starting antiretroviral therapy in resource-constrained settings: a reviewKoethe JR, Chi BH, Megazzini KM, Heimburger DC, Stringer JSA2009
12Occupational burnout, attrition, and HIV service utilization among healthcare workers in Lusaka, ZambiaKruse GR, Tambatamba BC, Ikeda S, Nkhoma M, Quiterio N, Pankratz D, Mataka K, Chi BH, Bond V, Reid S2009
13Predictors of rapid HIV testing acceptance and successful nevirapine administration in Zambian labor wardsMegazzini KM, Chintu N, Vermund SH, Redden DT, Krebs DW, Simwenda M, Tambatamba B, Sinkala M, Stringer JSA2009
14Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocolMwinga K, Vermund SH, Chen YQ, Mwatha A, Read JSA, Urassa W, Carpanetti N, Valentine M, Goldenberg RL2009
15Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settingsBecquet R, Ekouevi DK, Arrive E, Stringer JSA, Meda N, Chaix ML, Treluyer JM, Leroy V, Rouzioux C, Blanche S, Dabis F2009
16Use of open public dramas for health education and research participant recruitmentMwale S, Hachiboloma B, Stringer JSA2009
17Use of task-shifting and continuous quality improvement to rapidly scale-up HIV treatment services in the face of severe human resource constraints: experiences from Lusaka, ZambiaMorris M, Tambatamba B, Chi BH, Mwango A, Fusco H, Mwanza J, Manda H, Bolton C, Pankratz D, Stringer JSA, Reid SE2009
18  Acute hypophosphatemia and hypokalemia in a patient starting antiretroviral therapy in Zambia – a new context for refeeding syndrome? A case reportNyirenda C, Zulu I, Kabagambe EK, Bagchi S, Potter D, Bosire C, Krishnasami Z, Heimburger DC2009
1A pilot study of food supplementation to improve adherence to antiretroviral therapy among food insecure adults in Lusaka, ZambiaCantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, Tambatamba-Chapula B, Levy J, Stringer EM, Mulenga L, Stringer JSA2008
2Abandonment of antiretroviral therapy for local AIDS remedies: a potential barrier to scale-up in sub-Saharan AfricaReid SE, Mulenga LB, Folk WR, Tambatamba BC, Chi BH2008
3Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmissionChi BH, Chintu N, Cantrell RA, Kankasa C, Kruse G, Mbewe F, Sinkala M, Smith PJ, Stringer EM, Stringer JSA2008
4Baseline renal insufficiency and risk of death among HIV-infected adults initiating antiretroviral therapy in Lusaka, ZambiaMulenga L, Kruse G, Lakhi S, Cantrell RA, Reid S, Zulu I, Stringer EM, Krishnasami Z, Mwinga A, Saag MS, Stringer JSA, Chi BH2008
5Community-based follow-up for late patients enrolled in a district-wide program for antiretroviral therapy in Lusaka, ZambiaKrebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, Levy J, Sinkala M, Stringer JSA2008
6Declining HIV prevalence among young pregnant women in Lusaka, Zambia, 2002-2006Stringer EM, Chintu N, Levy J, Sinkala M, Chi BH, Muyanga J, Bulterys M, Megazzini K, Stringer JSA2008
7Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal periodBrown E, Chi BH, Read JSA, Taha TE, Sharma U, Hoffman IF, Goldenberg RL, Fiscus SA2008
8Do targeted HIV programs improve overall care for pregnant women? Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programsPotter D, Goldenberg RL, Chao A, Sinkala M, Degroot A, Stringer JSA, Bulterys M, Vermund SH2008
9Early lessons from integration of tuberculosis and HIV services in primary care centers in Lusaka, ZambiaHarris JB, Hatwiinda S, Randels KM, Chi BH, Kancheya NG, Jham MA, Samungole KVG, Tambatamba BC, Cantrell RA, Levy JW, Kimerling ME, Reid SE2008
10Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trialCelum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L; HPTN 039 Protocol Team2008
11Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan AfricaSutcliffe CG, van Kijk JH, Bolton C, Persaud D, Moss WJ2008
12Extended nevirapine prophylaxis to prevent HIV transmissionStringer JSA, Chi BH2008
13Hormonal contraception and HIV disease progressionStringer E, Antonsen E2008
14Integrating cervical cancer prevention in HIV/AIDS treatment and care programmesMwanahamuntu MH, Sahasrabuddhe VV, Stringer JSA, Parham GP2008
15Management of cryotherapy-ineligible women in a “see and treat” cervical cancer program targeting HIV-infected women in Zambia: lessons from the fieldPfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JSA, Parham GP2008
16Monitoring effectiveness of programs to prevent mother-to-child HIV transmission in lower-income countriesStringer EM, Chi BH, Chintu N, Creek T, Ekouvie D, Coetzee D, Tih P, Boulle A, Dabis F, Shaffer N, Wilfert CM, Stringer JSA2008
17Risk factors for late post-natal transmission of human immunodeficiency virus type 1Chasela C, Chen YQ, Fiscus S, Hoffman I, Young A, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JSA2008
18Simple adherence measures to predict virologic suppression among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapyGoldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, Limbada M, Taylor A, Saag MS, Vermund SH, Stringer JSA, Chi BH2008
19The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 studyRamjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B, HPTN 055 Study Team2008
1A randomized trial of the intrauterine contraceptive device (IUD) versus hormonal contraception in HIV-infected womenStringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, Matongo I, Vermund SH, Mwanahamuntu M, Stringer JSA2007
2Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countriesBolu OO, Allread V, Creek T, Stringer E, Forna F, Bulterys M, Shaffer2007
3Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource limited settings? Clin Inf Dis 2007; 44:135-8Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MSS2007
4Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in ZambiaBolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa B, Wilson CM, Wilfert CM, Mwango A, Levy J, Abrams EJ, Bulterys M, Stringer JSA2007
5Community perspectives on care options for HIV prevention trial participantsMacQueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S2007
6Complete Blood Count as a Surrogate CD4 Marker for HIV Monitoring in Resource-Limited SettingsChen RY, Westfall AO, Hardin AM, Miller-Hardwick C, Stringer JSA, Raper JL, Vermund SH, Gotuzzo E, Allison J, Saag MS2007
7Early clinical and immune response to NNRTI-based antiretroviral therapy among women exposed to single-dose nevirapine for prevention of mother-to-child HIV transmissionChi BH, Sinkala M, Stringer EM, Cantrell RA, Mtonga V, Bulterys M, Zulu I, Kankasa C, Wilfert C, Weidle PJ, Vermund SH, Stringer JSA2007
8Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, ZambiaChi BH, Chintu N, Lee A, Stringer EM, Sinkala M, Stringer JSA2007
9Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: a randomized controlled trialGoldenberg RL, Andrews WW, Hoffman I, Fawzi W, Valentine M, Young A, Read JS, Brown ER, Mudenda V, Kafulafula G, Mwinga K, Taha TE2007
10Influence of BMI on pregnancy outcomes of HIV-infected and -uninfected Zambian womenBanda Y, Chapman V, Goldenberg RL, Chi BH, Vermund SH, Stringer JSA2007
11Predictors of stillbirth in sub-Saharan AfricaChi BH, Wang L, Read JSA, Taha TE, Sinkala M, Brown ER, Valentine M, Martinson F, Goldenberg RL2007
12Prevalence and distribution of HPV-genotyping among HIV-infected women in ZambiaSahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JSA, Parham GP2007
13Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomized trialChi BH, Sinkala M, Mbewe F, Cantrell RA, Kruse G, Chintu N, Aldrovandi GM, Stringer EM, Kankasa C, Safrit J, Stringer JSA2007
14The global network: a prospective study of stillbirths in developing countriesMcClure EM, Wright LL, Goldenberg RL, Goudar SS, Parida SN, Jehan I, Tshefu A, Chomba E, Althabe F, Garces A, Harris H, Derman RJ, Panigrahi P, Engmann C, Buekens P, Hambidge M, Carlo WA2007
15Two Decades of the Safe Motherhood Initiative: Time for Another Wooden Spoon Award?Tita AT, Stringer JSA, Goldenberg RL, Rouse DJ2007
16Use of traditional medicines among pregnant women in Lusaka, ZambiaBanda Y, Chapman V, Goldenberg RL, Stringer JSA, Culhane JF, Sinkala M, Vermund SH, Chi BH2007